Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Journal of Psychopharmacology (Oxford, England)
|
August 29, 2020
The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial
James Gilleen, Judith Nottage, Farah Yakub, et al.
Scientific Reports
|
June 26, 2024
Distinct grey and white matter changes are associated with the phenomenology of visual hallucinations in Lewy Body Disease
Fabrizia D'Antonio, Alice Teghil, Maddalena Boccia, et al.
Nature. Mental Health
|
June 15, 2026
Deviations in effective connectivity explain different hallucination subtypes in Parkinson's disease psychosis
Miriam Vignando, Dominic Ffytche, Ndabezinhle Mazibuko, et al.
Journal of Alzheimer'S Disease : JAD
|
August 12, 2017
PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers
Ivan Koychev, Roger N Gunn, Azadeh Firouzian, et al.
Schizophrenia Bulletin
|
July 9, 2020
Hallucinations in Older Adults: A Practical Review
Johanna C Badcock, Frank Larøi, Karina Kamp, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 23, 2022
Neuropathological correlates of neuropsychiatric symptoms in dementia
Lucy L Gibson, Lea T Grinberg, Dominic Ffytche, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 18, 2011
Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study
Toby T Winton-Brown, Paul Allen, Sagnik Bhattacharyya, et al.
Brain Communications
|
October 2, 2024
Visual mismatch negativity in Parkinson's psychosis and potential for testing treatment mechanisms
Miriam Vignando, Dominic Ffytche, Ndabezinhle Mazibuko, et al.
Brain and Behavior
|
March 1, 2021
Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson's disease
Panteleimon Oikonomou, Daniel J van Wamelen, Daniel Weintraub, et al.
Nature Communications
|
January 27, 2022
Mapping brain structural differences and neuroreceptor correlates in Parkinson's disease visual hallucinations
Miriam Vignando, Dominic Ffytche, Simon J G Lewis, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Journal of Psychopharmacology (Oxford, England)
|
August 29, 2020
The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial
James Gilleen, Judith Nottage, Farah Yakub, et al.
Scientific Reports
|
June 26, 2024
Distinct grey and white matter changes are associated with the phenomenology of visual hallucinations in Lewy Body Disease
Fabrizia D'Antonio, Alice Teghil, Maddalena Boccia, et al.
Nature. Mental Health
|
June 15, 2026
Deviations in effective connectivity explain different hallucination subtypes in Parkinson's disease psychosis
Miriam Vignando, Dominic Ffytche, Ndabezinhle Mazibuko, et al.
Journal of Alzheimer'S Disease : JAD
|
August 12, 2017
PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers
Ivan Koychev, Roger N Gunn, Azadeh Firouzian, et al.
Schizophrenia Bulletin
|
July 9, 2020
Hallucinations in Older Adults: A Practical Review
Johanna C Badcock, Frank Larøi, Karina Kamp, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 23, 2022
Neuropathological correlates of neuropsychiatric symptoms in dementia
Lucy L Gibson, Lea T Grinberg, Dominic Ffytche, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 18, 2011
Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study
Toby T Winton-Brown, Paul Allen, Sagnik Bhattacharyya, et al.
Brain Communications
|
October 2, 2024
Visual mismatch negativity in Parkinson's psychosis and potential for testing treatment mechanisms
Miriam Vignando, Dominic Ffytche, Ndabezinhle Mazibuko, et al.
Brain and Behavior
|
March 1, 2021
Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson's disease
Panteleimon Oikonomou, Daniel J van Wamelen, Daniel Weintraub, et al.
Nature Communications
|
January 27, 2022
Mapping brain structural differences and neuroreceptor correlates in Parkinson's disease visual hallucinations
Miriam Vignando, Dominic Ffytche, Simon J G Lewis, et al.
Page
of 6